Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT01572623
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT01572623
-
- Other papers using this trial's data
- Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) study
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01572623. Randomized; no masking; primary purpose prevention. Start 2011-07 (registry gives no type); primary completion 2012-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting
- Acronym
- ARMYDA-CARO
- Condition
- Carotid Stenosis
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Atorvastatin
- Lead sponsor
- Campus Bio-Medico University
Record details
- Record id
cardio:ct-nct01572623- Content hash
3d43266ea6fb737201a2acd45b4cd59dc668659fe83fb08f60752d7636ee114c